BRCA1 and ovarian cancer: Our study shows an uptake rate of 96.1% in BRCA1‐2 PV carriers referred for first counselling to a specialised centre that focuses on individuals with genetic susceptibility to ovarian cancer, which is higher than the rates previously reported in the literature [21].